Research on insulin-like growth factor (IGF) and related proteins (i.e., IGF receptors and IGF-binding proteins (IGFBPs)) provides another plausible explanation and offers hope for a novel target in cancer therapy [12, 36, 40, 45]. This evidence concerns the gene IGF1 and cancer.